Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix ...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1,001-5,000 Employees
Year Founded:
2015 (11 years)
Address:
55 FLEMINGTON RD; NORTH MELBOURNE, VICTORIA 3051, AU
The company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
LOW
spending power